KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 147 filers reported holding KARUNA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,504,837 | +19.6% | 227,718 | +53.4% | 0.05% | +27.0% |
| Q2 2023 | $32,186,395 | +26.6% | 148,427 | +6.1% | 0.04% | +19.4% |
| Q1 2023 | $25,417,793 | +28.5% | 139,935 | +39.0% | 0.03% | +29.2% |
| Q4 2022 | $19,783,817 | +14.8% | 100,681 | +31.1% | 0.02% | +9.1% |
| Q3 2022 | $17,237,000 | +240.9% | 76,781 | +92.1% | 0.02% | +266.7% |
| Q2 2022 | $5,057,000 | -14.2% | 39,971 | -14.0% | 0.01% | +20.0% |
| Q1 2022 | $5,892,000 | -4.8% | 46,471 | -1.6% | 0.01% | 0.0% |
| Q4 2021 | $6,189,000 | +26.8% | 47,247 | +18.4% | 0.01% | 0.0% |
| Q3 2021 | $4,882,000 | +12.4% | 39,910 | +5.0% | 0.01% | +25.0% |
| Q2 2021 | $4,342,000 | -2.4% | 38,010 | +2.7% | 0.00% | -20.0% |
| Q1 2021 | $4,451,000 | +54.1% | 37,018 | +30.2% | 0.01% | +25.0% |
| Q4 2020 | $2,889,000 | +31.4% | 28,437 | 0.0% | 0.00% | +33.3% |
| Q3 2020 | $2,199,000 | -26.7% | 28,437 | +5.6% | 0.00% | -25.0% |
| Q2 2020 | $3,002,000 | +58.3% | 26,937 | +2.3% | 0.00% | +33.3% |
| Q1 2020 | $1,896,000 | -5.9% | 26,337 | -1.5% | 0.00% | 0.0% |
| Q4 2019 | $2,014,000 | +438.5% | 26,737 | +16.6% | 0.00% | +200.0% |
| Q3 2019 | $374,000 | – | 22,931 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |